The Prognostic Implication of Metabolic Syndrome in Patients with Heart Failure
Hyun Ju Yoon(Chonnam National University Hospital), Eun‐Seok Jeon, Kyu-Hyung Ryu(Hallym University Dongtan Sacred Heart Hospital), Dong‐Ju Choi(Inserm), Myung-Chan Cho(Chungbuk National University), Jae‐Joong Kim(Inje University), Kye Hun Kim(Chonnam National University), Mi‐Seung Shin(Ewha Womans University), Byung‐Su Yoo(University of San Diego), Byung‐Hee Oh(Sejong General Hospital), Jong Chun Park(Chonnam National University Hospital), Seok‐Min Kang(Harvard University), Myung-Mook Lee(Dongguk University Ilsan Hospital), Yung-Jo Kim(Yeungnam University Medical Center), Shung Chull Chae(Kyungpook National University Hospital), Youngkeun Ahn(Chonnam National University Hospital), In Whan Seong(University of Ulsan), Seongwoo Han(Hallym University Kangnam Sacred Heart Hospital), Hyung Seop Kim(Keimyung University)
Cited by 18
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493